Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

COPA Genetic Mutation Identified in Lung Disease, Arthritis

Lara C. Pullen, PhD  |  Issue: June 2014, June 2015  |  June 15, 2015

A great deal of what is known about COPA comes from analysis of yeast. Randy Sheckman, PhD, of the University of California, Berkeley was awarded the Nobel Prize in Physiology or Medicine in 2013 for his discoveries of machinery regulating vesicle traffic. He identified a complex of three proteins that together attach to the surface of the endoplasmic reticulum. This attachment must precede budding of the membrane and the formation of transport vesicles. The complexes are known as coat protein complex I (COPI) and coat protein complex II (COPII). Thousands of these complexes coat the budding surface of a vesicle, creating a sac and recruiting the correct protein cargo. COPA represents a subunit of COPI and appears to be important in intra­cellular transport via COPI. Although COPII transports from the rough ER to the Golgi complex, COPI transports from the Golgi complex to the rough ER. The pathways have been fleshed out to some extent; however, most of the research has taken place in yeast, and the system has not been well studied in mammalian cells.

Once COPA had been identified as the relevant protein, the investigators measured COPA expression in the affected patients. They were surprised to discover that COPA was expressed at normal levels in these individuals. Recognizing the essential nature of the COPA protein for intracellular transport, Dr. Shum and colleagues next determined the functional consequence of the COPA variants. They hypothesized that the mutant COPA resulted in defective intracellular transport via COPI. This was supported by the observation that the COPA mutations seen in the patients appeared to render the protein dysfunctional. Further investigation revealed that the COPA variants impaired binding to proteins targeted for retrograde transport (Golgi-to-ER). Although the experiments stopped short of specifically demonstrating a trafficking defect, such a defect is the most likely explanation for the data.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Trigger of Autoimmunity

The investigators then sought to identify physiological effects of COPA variants that might link the mutation mechanistically with autoimmune disease. They performed dynamic functional assessments of patient-derived cells and found evidence of ER stress in patients with mutant COPA. In an attempt to understand the specific role of mutant COPA on ER stress, the researchers performed small interfering RNA (siRNA)–mediated knockdown experiments in human embryonic kidney (HEK) cells. The results confirmed the ER stress, but the investigators were unable to determine how the ER stress led to autoimmunity. Although the path to pathology has not yet been elucidated, the authors propose the possibility that the COPA mutation might compromise autophagy. The hypothesis stems from previous studies that have indicated an association between autophagy and autoimmunity.

Patients do not need to have a clear family history in order to indicate that a COPA mutation is important in their pathology.

The team next examined CD4+ T cells in individuals with mutant COPA. They found that patient-derived CD4+ T cells were significantly skewed toward the T helper type 17 (Th17) phenotype implicated in autoimmunity. Moreover, BLCLs derived from patients with mutant COPA showed significant elevations of transcripts encoding interleukin (IL) 1β, IL-6 and IL-23. Thus, faulty protein trafficking by mutant COPA resulted in cellular stress as well as upregulation of cytokines that triggered a Th17 response. The investigators hypothesize that such an impairment in the cellular trafficking may mean that misfolded proteins are being mistakenly released. It is possible that these misfolded proteins trigger an autoimmune response due to their cryptic nature.

Why the Lung?

The investigators do not have an explanation for why this mutation preferentially affects the lung. “That’s the big mystery,” noted Dr. Shum. “Why the lung? Why the joint?” COPA is ubiquitously expressed and so it seems strange that the autoimmune syndrome is restricted to the lung and joints. He hypothesized that cells in the lung and joint may be particularly dependent on the retrograde transport.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsResearch Rheum Tagged with:Arthritisautoimmunity syndromeCOPAgenetic mutationjointlung diseaseResearch

Related Articles

    COPA Syndrome: What Do We Know About This Rare Disease?

    April 17, 2021

    ACR CONVERGENCE 2020—Tiphanie Phillips Vogel, MD, PhD, assistant professor of pediatrics and internal medicine at Baylor College of Medicine, Houston, moderated the session on COPA syndrome, which drew 324 attendees on a Sunday morning. This rare genetic cause of immune dysregulation can present like anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis, lupus, lupus nephritis or rheumatoid…

    2015 ACR/ARHP Annual Meeting: Next Generation Sequencing and Disease Mechanisms

    February 17, 2016

    SAN FRANCISCO—By harnessing the power of next generation sequencing strategies and combining them with clever statistical strategies and tools, investigators are striving to define causal pathways of and mechanisms underlying complex diseases, such as rheumatoid arthritis, according to Soumya Raychaudhuri, MD, PhD, associate professor, Harvard Medical School, Brigham and Women’s Hospital, Boston, during a session…

    What Listening to Lungs Might Teach About Rheumatic Disease

    February 17, 2016

    One of your first clinical assignments as a medical student was likely to have been the lung exam. Its key descriptors may still resonate in your mind: inspection, palpation, percussion and auscul­tation. Proudly parading down the hospital corridors, your newly purchased stethoscope snugly tucked inside your lab coat pocket, you carefully place its cold metal…

    A History of the Science, Treatment of Rheumatologic Illnesses from Gold to Gene Therapy

    December 17, 2017

    Mysterious Ways The juxtaposition of the old and the new was readily evident that busy Wednesday morning. My first patient, a 94-year-old gentleman, Hal, arrived with a precise request. His rheumatologist for the past 40 years had just retired, and he was searching for a doctor with expertise in the use of gold sodium aurothioglucose,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences